The Hidden Tech Stack of a Clinical Trial

How Many Software Systems Does One Clinical Trial Actually Need?

Hub-and-spoke diagram showing "One Trial" at the center connected to ten different software systems used to run a clinical trial, including EDC, CTMS, eTMF, RTSM, Safety Database, eConsent, ePRO, SharePoint, Excel, and MS Project.  Same note as last time: if Blogger's uploader has trouble with SVG on your setup, open it in a browser and export as PNG — flat colors like this compress to well under 100 KB with no quality loss.  Clinical trial tech sprawl header Bild


Ask someone outside the industry to guess how many software systems a single clinical trial runs on, and they'll probably say two or three: something to collect patient data, something to manage the study. Ask someone who actually staffs a site, and the answer is closer to twenty.

This isn't exaggeration. It's documented, repeatedly, across multiple independent industry surveys. And once you start counting, the financial and human cost of that sprawl becomes hard to ignore.

The inventory: what actually runs a trial

A realistic multi-site trial typically touches systems across at least six layers:

Core eClinical systems

  • EDC (Electronic Data Capture) for patient-level data collection
  • CTMS (Clinical Trial Management System) for enrollment, site performance, milestones, budgets
  • RTSM/IRT for randomization and drug supply management
  • eTMF for trial master file / regulatory document repository
  • eConsent for electronic informed consent
  • ePRO/eCOA for patient-reported and clinical outcome assessments
  • Safety database for adverse event and SAE reporting/pharmacovigilance

Site start-up and site-facing tools

  • Feasibility and site qualification portals
  • eISF (electronic Investigator Site File)
  • LMS (Learning Management System) for GCP and protocol training
  • Site payment / grant management portals

Data and analytics

  • CDMS / data warehouse for cleaning, query management, database lock
  • BI/reporting dashboards
  • RBQM (risk-based quality management) tools

Finance and contracts

  • CTFM (clinical trial financial management) platforms
  • Budgeting and invoice/payment systems

The "invisible" layer everyone forgets to count

  • Excel for everything the "real" systems don't cover
  • Word protocol drafts, informed consent forms, correspondence
  • SharePoint / shared drives for document version control, storage and backup
  • Outlook / Teams for day-to-day coordination, issue resolution
  • MS Project (or equivalent) for timeline and milestone tracking

Line up all six layers for a single mid-size multi-site trial, and a count of 15–20 distinct systems is common, before counting the general office tools most teams don't think of as "trial technology" at all, but that every coordinator uses daily.

This is not a guess, the data backs it up

Independent surveys have quantified this repeatedly, and the trend line only moves in one direction:

  • A 2013 Intralinks web portal survey found that 88% of investigator sites accessed three or more clinical web portals, and 53% accessed six or more — meaning the fragmentation problem was already well established over a decade ago (Intralinks 2013 Web Portal Survey).
  • Florence's 2022 Clinical Trial Operations Technology Survey found 42% of sites logging into five or more platforms for an average study, with 40% citing lack of system integration as a major adoption barrier (Florence, 2022).
  • Advarra's 2024 Site-Sponsor-CRO Collaboration Survey found nearly 70% of site respondents reporting six or more logins per study, and 55% rating sponsor technology setup and training as extremely or very burdensome, an experience 67% said had gotten worse over the prior five years (Advarra, 2024, via Applied Clinical Trials).
  • A separate Advarra analysis put the average at four to six sponsor-provided technology logins per trial, with 80% of sites saying the ability to use their own credentials across systems would be highly valuable (Advarra Checklist).
  • At the high end, Medidata notes that a site relying on disparate sponsor-provided technologies can end up using twenty-plus systems a day, and that five vendors can translate into as many as fifty separate logins once every portal, training system, and query tool is counted (Medidata).
  • Tufts CSDD's global survey of 387 investigative site professionals documented persistent burdens tied specifically to fragmented systems, training demands, and financial strain, alongside genuine, growing site-level investment in digital tools (Tufts CSDD, via Applied Clinical Trials).

The consistency across a decade of independent surveys from different organizations, different methodologies, different years, is itself the finding. This isn't one vendor's marketing statistic; it's a structural feature of how trials are run today.

What it actually costs

Pricing is not standardized across this landscape, but public estimates give a workable range:

  • EDC systems: roughly $10,000 for a small academic study up to $500,000+ for a large global Phase III trial, once setup, integrations, training, and hosting are included, not just the base license (ClinCapture EDC Pricing Guide, 2026). A smaller estimate for an 18-month Phase I oncology study puts total EDC cost around $66,000, combining a roughly $12,000 build with a $3,000/month hosting fee (Sofpromed).
  • CTMS systems: enterprise licensing commonly runs $1,500–$3,000 per user depending on modules, before implementation labor and integration costs are added (Quora/industry estimate); first-year total cost estimates range from roughly $4,000 for a minimal setup to over $500,000 for a fully customized enterprise deployment (AQ Trials CTMS Cost Guide).
  • Site start-up as a whole, which includes CTMS/EDC build, system access setup, and account provisioning across all these platforms is now estimated to comprise roughly 40% of total trial budgets, a cost driver industry analysts say has historically been under-measured (IntuitionLabs, Clinical Trial Start-Up Costs).
  • Protocol amendments, which typically require re-touching multiple systems (EDC forms, training materials, consent documents) simultaneously, are estimated to cost $500,000+ in direct costs and add three or more months of delay per amendment (Clincove Budget Guide, 2026).

None of these figures include the recurring, harder-to-line-item cost of staff time spent re-entering the same data across systems that don't talk to each other — which is where the human cost starts to show up in the budget indirectly.

The human cost: burnout and turnover

This is the part of the equation that rarely makes it into a budget spreadsheet, but the research is direct about the connection between system burden and staff attrition.

  • A peer-reviewed study of U.S. clinical research coordinators found that roughly 44% reported high emotional exhaustion — a core component of burnout — with high perceived daily workload and low job satisfaction as the strongest independent predictors (Burnout in Clinical Research Coordinators in the United States, PubMed).
  • Turnover for clinical research associates hovers around 30%, a rate that compounds the burden on remaining staff and accelerates further attrition (Applied Clinical Trials, "Can Clinical Trials Overcome Their Staffing Problem?"). Separately, the CRO industry overall has been reported at a 24–29% turnover rate, roughly double the average U.S. cross-industry rate of 15% (Florence, "Combating Burnout in Clinical Research").
  • Replacing a clinical research professional is estimated to cost around $25,000 and take roughly three months to bring a new hire to full productivity, a cost incurred every time system fatigue, administrative load, or frustration pushes someone out the door (Florence).
  • Site staff themselves connect the dots explicitly: in the 2024 Advarra survey, one anonymous site respondent described having too many portals and systems requiring unique credentials and two-factor authentication for dozens of staff, calling it a serious challenge to maintaining operational consistency and training new hires (Applied Clinical Trials, 2026).

The pattern across these sources is consistent: workload and system friction are named, repeatedly and independently, as drivers of the same emotional exhaustion and attrition that then costs sponsors real money to replace — a loop where the technology meant to make trials more efficient can, past a certain point, work against the people running them.

Project-Owner View

The industry has spent two decades adding specialized systems to solve specialized problems and each addition made sense in isolation. EDC solved data quality. CTMS solved operational visibility. eTMF solved document control. RTSM solved supply chain complexity. None of these were bad decisions individually.

But nobody was responsible for counting the cumulative total, or its cost, financial or human, until fairly recently. The data above suggests three things worth taking seriously in any trial planning conversation:

  1. Tool count should be a tracked metric, the same way budget and timeline are. A "systems per site" number, established at protocol design stage, is a leading indicator of both cost and staff burden — not an afterthought to be discovered during site activation.
  2. Consolidation and single sign-on are not nice-to-haves. When 80% of sites say their own credentials across systems would be valuable, and 42–70% report five-plus logins per study depending on the survey year, this is a solvable operational problem, not an unavoidable cost of doing research.
  3. The financial and human costs are the same cost, viewed from two angles. A $25,000 replacement cost per departed coordinator and a 24–29% CRO turnover rate are not separate from the "just" $10,000–$500,000 spent on EDC and CTMS licenses, they are downstream of the same underlying sprawl.

The question worth asking at protocol design, not after site activation, may not be "which systems do we need" but "how many systems can this trial actually justify" and who is accountable for that number once it's set.

Sources

Disclaimer: This article is an educational discussion prepared for informational purposes. Cost figures are drawn from public vendor and industry sources and vary significantly by trial size, phase, therapeutic area, and region, treat them as directional benchmarks, not quotes. This does not constitute financial, legal, or procurement advice.

Comments

Popular posts from this blog

Project Management Software

Making Unaccounted Costs Accountable in Clinical Research

Clinical Research on Hypnosis: Evidence and Applications